Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px
Organisation › Details

Sarepta Therapeutics Inc. (NASDAQ: SRPT)

Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases. The Company is primarily focused on rapidly advancing the development of its potentially disease-modifying DMD drug candidates, including EXONDYS 51, designed to skip exon 51 and approved under the accelerated approval pathway. *

 

Period Start 2016-09-22 existent
Products Industry RNA-based therapeutic
  Industry 2 DRUGS, ORPHAN
     
Region Region Cambridge, MA
  Country United States (USA)
  Street 215 First Street
  City 02142 Cambridge, MA
  Tel +1-617-274-4000
    Address record changed: 2016-09-30
     
Basic data Employees n. a.
     
    * Document for �About Section�: SareptaTherapeutics, Inc.. (9/22/16). "Press Release: Sarepta Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock". Cambridge, MA.
     
   
Record changed: 2019-03-06

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for Sarepta Therapeutics Inc. (NASDAQ: SRPT)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top